Brian L. Pearlman

3.5k citations
43 papers · 1.3k indexed · h-index 18
Topics
Hepatitis C virus research (35 papers)Liver Disease Diagnosis and Treatment (23 papers)Hepatitis B Virus Studies (20 papers)

In The Last Decade

Brian L. Pearlman

42 papers receiving 1.3k citations

Peers

Brian L. Pearlman
Comparison fields: 5 of 95
  • Hepatology 1.0k
  • Epidemiology 919
  • Infectious Diseases 229
  • Rheumatology 84
  • Molecular Biology 81
Replace Murray N. Ehrinpreis with:
Murray N. Ehrinpreis United States
Jean–Jacques Garaud France
Benjamin Maasoumy Germany
Edna Strauss Brazil
Sabela Lens Spain
Joan Miller United States
Fulvio Mozzi Italy
Ziv Ben Ari Israel
Obaid S. Shaikh United States
Alejandro Soza Chile
Brian L. Pearlman relative to Murray N. Ehrinpreis United States Murray N. Ehrinpreis's profile →
Citations per field
00.5×2.8×
Murray N. Ehrinpreis · 1×
Citations per year

Countries citing papers authored by Brian L. Pearlman

Since Specialization
Citations

This map shows the geographic impact of Brian L. Pearlman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian L. Pearlman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian L. Pearlman more than expected).

Fields of papers citing papers by Brian L. Pearlman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian L. Pearlman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian L. Pearlman. The network helps show where Brian L. Pearlman may publish in the future.

Co-authorship network of co-authors of Brian L. Pearlman

This figure shows the co-authorship network connecting the top 25 collaborators of Brian L. Pearlman. A scholar is included among the top collaborators of Brian L. Pearlman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian L. Pearlman. Brian L. Pearlman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 6
3 0
4 34
5 2
6 34
7 6
8 124
9 46
10 72
11 11
12 14
13 84
14 17
15 45
16 11
17 7
18 11
19 61
20 34

About Brian L. Pearlman

Brian L. Pearlman is a scholar working on Hepatology, Epidemiology and Infectious Diseases, having authored 43 papers that have together received 1.3k indexed citations. Recurring topics across this work include Hepatitis C virus research (35 papers), Liver Disease Diagnosis and Treatment (23 papers) and Hepatitis B Virus Studies (20 papers). The work is most often cited by research in Hepatology (1.0k citations), Epidemiology (919 citations) and Infectious Diseases (229 citations). Brian L. Pearlman has collaborated with scholars based in United States, France and Canada. Frequent co-authors include NE Traub, Carole Ehleben, Lawrence Serfaty, Michael Robertson, Andrew Z. Fenves, Michael Emmett, Janice Wahl, Paul Y. Kwo, Paul Stryszak and Cheng‐Yuan Peng. Their work appears in journals such as The Lancet, Gastroenterology and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026